脾脏硬化性血管瘤样结节性转化超声表现1例

2019-11-12 余锴 梅云华 临床超声医学杂志

患者女,27岁,因体检发现脾门区肿瘤入院。超声检查:脾脏切面形态失常,实质点状强回声分布不均匀,脾门区可见一个大小为5.2 cm×4.3 cm×4.7 cm的团状低回声向脾脏内凸起,边界欠清晰,内回声不均匀,可见高回声条索样分隔,呈“分叶状”改变。脾门区脾静脉受压迫(图1);CDFI示上述肿块内可见血流信号,周边可见多条血管由肿块表面直插入肿块中心,呈“轮辐状”(图2)。超声提示:脾门区实质性占位

患者女,27岁,因体检发现脾门区肿瘤入院。超声检查:脾脏切面形态失常,实质点状强回声分布不均匀,脾门区可见一个大小为5.2 cm×4.3 cm×4.7 cm的团状低回声向脾脏内凸起,边界欠清晰,内回声不均匀,可见高回声条索样分隔,呈“分叶状”改变。脾门区脾静脉受压迫(图1);CDFI示上述肿块内可见血流信号,周边可见多条血管由肿块表面直插入肿块中心,呈“轮辐状”(图2)。超声提示:脾门区实质性占位性病变(血管瘤?其他占位性病变)。CT提示:脾门区占位,考虑血管瘤可能。


图1 二维超声示肿块边界不清,内部回声不均匀,呈分叶状改变


图2 CDFI可探及数条血管由瘤体外直插进入瘤体中心
 
因肿块体积较大,生长迅速,且已压迫脾静脉,行腹腔镜下全脾切除术。手术所见:肿瘤为单结节状病灶,瘤体部分位于脾脏实质内,边界与脾组织交错,无明显包膜。病理检查:肿瘤切面呈灰白或灰红色,质地较韧,病灶内可见多条由瘢痕样灰白色条索穿插分隔形成的大小不等的灰红色结节。
 
镜下病变表现为显著增生并胶原化的纤维组织包绕多个血管瘤样结节,结节大小不等,互相融合。免疫组化结果:VIM(+),SMA(+),CD31(+),CD34(散在+),CD4(散在少许+),CD8(散在少许+),CD68(散在+),IgG(散在+),IgG4(散在少许+),IgG4/IgG<40%,CD35(少许弱+),CD21(-),CD23(-),EBER(-),Ki67LI约5%。符合脾脏硬化性血管瘤样结节性转化(sclerosing angiomatoid nodular transformation,SANT)。术后预后良好,无复发。
 
讨论:
 
SANT是近年新确认的一种病因尚不明确的脾脏良性病变,由Martel等于2004年提出,由于该病较为罕见,临床缺乏足够的认识,过去常被误诊为错构瘤、血管瘤或其他恶性肿瘤。其超声影像学表现有一定的特异性,即二维超声的瘤体“分叶状”改变,CDFI示血管由瘤体外直插入瘤体中心呈“轮辐状”,本病例即是如此。由于该病血供较丰富,瘤体生长迅速,不到一年时间内超过5 cm。了解此特征可以提高脾脏肿瘤的术前诊断能力。但最终确诊仍需术后病理检查。SANT的预后良好,脾脏切除即可治愈,随访尚未发现有复发病例的相关报道。
 
原始出处:

余锴,梅云华.脾脏硬化性血管瘤样结节性转化超声表现1例[J].临床超声医学杂志,2018,20(06):387.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1003299, encodeId=2b121003299c8, content=见到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=ms8000000567865076, createdTime=Wed Jul 28 12:16:16 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693585, encodeId=d04b16935855a, content=<a href='/topic/show?id=cb16e883013' target=_blank style='color:#2F92EE;'>#结节性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78830, encryptionId=cb16e883013, topicName=结节性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8429436174, createdName=crystal0572, createdTime=Thu Jul 16 04:04:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632687, encodeId=dd36163268eaf, content=<a href='/topic/show?id=676d92821e3' target=_blank style='color:#2F92EE;'>#超声表现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92821, encryptionId=676d92821e3, topicName=超声表现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfe21938258, createdName=zhangjingnwpu, createdTime=Tue Apr 07 20:04:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375373, encodeId=ccb13e537341, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:15 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375372, encodeId=a6b43e53729c, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:05 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348298, encodeId=58f0134829884, content=<a href='/topic/show?id=1eaf89e26d3' target=_blank style='color:#2F92EE;'>#血管瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89726, encryptionId=1eaf89e26d3, topicName=血管瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496355, encodeId=0e3b14963552c, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=)]
    2021-07-28 ms8000000567865076

    见到过

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1003299, encodeId=2b121003299c8, content=见到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=ms8000000567865076, createdTime=Wed Jul 28 12:16:16 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693585, encodeId=d04b16935855a, content=<a href='/topic/show?id=cb16e883013' target=_blank style='color:#2F92EE;'>#结节性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78830, encryptionId=cb16e883013, topicName=结节性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8429436174, createdName=crystal0572, createdTime=Thu Jul 16 04:04:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632687, encodeId=dd36163268eaf, content=<a href='/topic/show?id=676d92821e3' target=_blank style='color:#2F92EE;'>#超声表现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92821, encryptionId=676d92821e3, topicName=超声表现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfe21938258, createdName=zhangjingnwpu, createdTime=Tue Apr 07 20:04:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375373, encodeId=ccb13e537341, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:15 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375372, encodeId=a6b43e53729c, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:05 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348298, encodeId=58f0134829884, content=<a href='/topic/show?id=1eaf89e26d3' target=_blank style='color:#2F92EE;'>#血管瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89726, encryptionId=1eaf89e26d3, topicName=血管瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496355, encodeId=0e3b14963552c, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1003299, encodeId=2b121003299c8, content=见到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=ms8000000567865076, createdTime=Wed Jul 28 12:16:16 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693585, encodeId=d04b16935855a, content=<a href='/topic/show?id=cb16e883013' target=_blank style='color:#2F92EE;'>#结节性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78830, encryptionId=cb16e883013, topicName=结节性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8429436174, createdName=crystal0572, createdTime=Thu Jul 16 04:04:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632687, encodeId=dd36163268eaf, content=<a href='/topic/show?id=676d92821e3' target=_blank style='color:#2F92EE;'>#超声表现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92821, encryptionId=676d92821e3, topicName=超声表现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfe21938258, createdName=zhangjingnwpu, createdTime=Tue Apr 07 20:04:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375373, encodeId=ccb13e537341, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:15 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375372, encodeId=a6b43e53729c, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:05 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348298, encodeId=58f0134829884, content=<a href='/topic/show?id=1eaf89e26d3' target=_blank style='color:#2F92EE;'>#血管瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89726, encryptionId=1eaf89e26d3, topicName=血管瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496355, encodeId=0e3b14963552c, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1003299, encodeId=2b121003299c8, content=见到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=ms8000000567865076, createdTime=Wed Jul 28 12:16:16 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693585, encodeId=d04b16935855a, content=<a href='/topic/show?id=cb16e883013' target=_blank style='color:#2F92EE;'>#结节性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78830, encryptionId=cb16e883013, topicName=结节性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8429436174, createdName=crystal0572, createdTime=Thu Jul 16 04:04:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632687, encodeId=dd36163268eaf, content=<a href='/topic/show?id=676d92821e3' target=_blank style='color:#2F92EE;'>#超声表现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92821, encryptionId=676d92821e3, topicName=超声表现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfe21938258, createdName=zhangjingnwpu, createdTime=Tue Apr 07 20:04:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375373, encodeId=ccb13e537341, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:15 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375372, encodeId=a6b43e53729c, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:05 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348298, encodeId=58f0134829884, content=<a href='/topic/show?id=1eaf89e26d3' target=_blank style='color:#2F92EE;'>#血管瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89726, encryptionId=1eaf89e26d3, topicName=血管瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496355, encodeId=0e3b14963552c, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=)]
    2019-11-16 14794e5bm67(暂无昵称)

    非常受益,很好的研究

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1003299, encodeId=2b121003299c8, content=见到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=ms8000000567865076, createdTime=Wed Jul 28 12:16:16 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693585, encodeId=d04b16935855a, content=<a href='/topic/show?id=cb16e883013' target=_blank style='color:#2F92EE;'>#结节性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78830, encryptionId=cb16e883013, topicName=结节性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8429436174, createdName=crystal0572, createdTime=Thu Jul 16 04:04:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632687, encodeId=dd36163268eaf, content=<a href='/topic/show?id=676d92821e3' target=_blank style='color:#2F92EE;'>#超声表现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92821, encryptionId=676d92821e3, topicName=超声表现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfe21938258, createdName=zhangjingnwpu, createdTime=Tue Apr 07 20:04:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375373, encodeId=ccb13e537341, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:15 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375372, encodeId=a6b43e53729c, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:05 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348298, encodeId=58f0134829884, content=<a href='/topic/show?id=1eaf89e26d3' target=_blank style='color:#2F92EE;'>#血管瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89726, encryptionId=1eaf89e26d3, topicName=血管瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496355, encodeId=0e3b14963552c, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=)]
    2019-11-16 14794e5bm67(暂无昵称)

    非常受益,很好的研究

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1003299, encodeId=2b121003299c8, content=见到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=ms8000000567865076, createdTime=Wed Jul 28 12:16:16 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693585, encodeId=d04b16935855a, content=<a href='/topic/show?id=cb16e883013' target=_blank style='color:#2F92EE;'>#结节性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78830, encryptionId=cb16e883013, topicName=结节性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8429436174, createdName=crystal0572, createdTime=Thu Jul 16 04:04:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632687, encodeId=dd36163268eaf, content=<a href='/topic/show?id=676d92821e3' target=_blank style='color:#2F92EE;'>#超声表现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92821, encryptionId=676d92821e3, topicName=超声表现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfe21938258, createdName=zhangjingnwpu, createdTime=Tue Apr 07 20:04:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375373, encodeId=ccb13e537341, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:15 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375372, encodeId=a6b43e53729c, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:05 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348298, encodeId=58f0134829884, content=<a href='/topic/show?id=1eaf89e26d3' target=_blank style='color:#2F92EE;'>#血管瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89726, encryptionId=1eaf89e26d3, topicName=血管瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496355, encodeId=0e3b14963552c, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1003299, encodeId=2b121003299c8, content=见到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab585558129, createdName=ms8000000567865076, createdTime=Wed Jul 28 12:16:16 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693585, encodeId=d04b16935855a, content=<a href='/topic/show?id=cb16e883013' target=_blank style='color:#2F92EE;'>#结节性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78830, encryptionId=cb16e883013, topicName=结节性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8429436174, createdName=crystal0572, createdTime=Thu Jul 16 04:04:00 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632687, encodeId=dd36163268eaf, content=<a href='/topic/show?id=676d92821e3' target=_blank style='color:#2F92EE;'>#超声表现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92821, encryptionId=676d92821e3, topicName=超声表现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfe21938258, createdName=zhangjingnwpu, createdTime=Tue Apr 07 20:04:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375373, encodeId=ccb13e537341, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:15 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375372, encodeId=a6b43e53729c, content=非常受益,很好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Sat Nov 16 19:06:05 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348298, encodeId=58f0134829884, content=<a href='/topic/show?id=1eaf89e26d3' target=_blank style='color:#2F92EE;'>#血管瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89726, encryptionId=1eaf89e26d3, topicName=血管瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496355, encodeId=0e3b14963552c, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Thu Nov 14 14:04:00 CST 2019, time=2019-11-14, status=1, ipAttribution=)]

相关资讯

脾脏少见良性肿瘤病变!

男性,50岁。右上腹反复不适10余年。

脾脏硬化性血管瘤样结节性转化1例报告

病人男性,36岁。因体检(腹部超声)发现脾脏占位性病变1个月于2016-11-08就诊吉林大学第一医院肝胆胰外二科治疗。病程中无发热,无恶心、呕吐,二便正常,无贫血貌,皮肤巩膜无黄染,全身淋巴结未触及肿大。

女孩脾脏长满密密麻麻的虫卵,医生切开后起一身鸡皮疙瘩

“姑娘,你的脾怎么变成一个死疙瘩了?”

NEJM:脾脏中的空气哪来的?-病例报道

患者接受了剖腹探查,在此期间,在胃大弯上确定了直径为2cm的溃疡,并发展成瘘管直通脾脏。该患者进行了脾切除术和胃楔形切除术。组织学检查证实了消化性溃疡病的诊断。

脾脏异位妊娠的超声诊断

病例1:女,29岁,主诉:停经50d,阴道流血3d。体格检查:腹部无明显压痛及反跳痛;宫颈无抬举痛,双附件区无明显压痛。实验室检查:人绒毛膜促性腺激素(human chorionic gonadotropin,HCG)16669mIU/ml,孕酮11.52ng/ml。

无功能性胰腺神经内分泌瘤侵及脾脏一例

患者男,49岁。近1年消瘦30余斤,在外院门诊行CT检查,发现脾门区占位性病变。1周后入本院进一步诊治。患者高血压病2年余,既往无腹痛、头晕、腹泻、贫血等症状。